Kyowa Hakko’s Citicoline obtains Novel Food Registration status in Europe.
Kyowa Hakko Europe GmbH is a 100% affiliate company of Kyowa Hakko Bio Co. Ltd. (a wholly owned subsidiary of Kyowa Hakko Kirin Co., Ltd.) a Japanese company with combined strengths in bio-technologies and chemical synthesis to develop an extensive array of innovative high quality products.
We are a pioneer in the development, application and production of fermentation technology and maintain an ongoing commitment to research, developing innovative new products and quality management.
Together with our daughter company Kyowa Hakko Bio Italiana S.R.L. we are the European Sales Force serving the European, CIS and African countries as well as the near middle east market with various fine chemical products.
Our business is centered on amino acids, vitamins and nucleic acids as well as the derivatives of such for use in pharmaceuticals, nutritional supplements and industrial applications. Besides vitamins our division Daiichi Fine Chemical offers a wide range of materials for the personal care industry.
MAGHREB PHARMA 2014
20-22 September 2014, Hilton Exhibition Area, Algiers/Algeria
our booth no. is C41
CPHI WORLDWIDE 2014
7-9 October 2014, Paris Nord Villepinte, France
our booth no. is 3H17